Communiqués de presse MHRA — Medicines and Healthcare products Regulatory Agency — Flux RSS et veille en direct
PPN World suit le flux RSS de MHRA — Medicines and Healthcare products Regulatory Agency en temps réel — 7 communiqués indexés au cours des 30 derniers jours, le plus récent est arrivé il y a 3 j. Suivez-le avec alertes sur recherches enregistrées, résumés IA et recherche plein texte, ou branchez l'URL RSS ci-dessous dans votre propre lecteur.
À propos de ce fil
MHRA — Medicines and Healthcare products Regulatory Agency fait partie des 1,200+ fils de presse que PPN World surveille en continu — un fil en anglais axé sur le secteur Santé & sciences de la vie, classé sous « Royaume-Uni » dans notre index par pays. Chaque communiqué est dédupliqué, géolocalisé et enrichi d'un résumé IA, et vous pouvez y attacher des alertes sur recherches enregistrées. MHRA — Medicines and Healthcare products Regulatory Agency est un fil spécialisé à faible volume — 7 communiqués dans les 30 derniers jours : le genre de source qui mérite une alerte plutôt qu'un défilement.
Suivez MHRA — Medicines and Healthcare products Regulatory Agency en temps réel dans PPN World
Chaque communiqué de MHRA — Medicines and Healthcare products Regulatory Agency arrive dans le cockpit quelques secondes après sa publication — dédupliqué, classé, avec alertes sur recherches enregistrées et résumés IA, aux côtés de 1,200+ autres fils. Essai gratuit de 7 jours, sans carte.
Commencer l'essai gratuit →Derniers communiqués de MHRA — Medicines and Healthcare products Regulatory Agency
- Independent Commission led by NHS doctors sets out blueprint to accelerate safe AI adoption in healthcareil y a 3 j
New recommendations based on extensive public engagement set out how the NHS could give patients faster access to AI advances with proportionate safeguards to protect patient safety and maintain high…
- MHRA and Manchester NHS partner on health innovation sandboxil y a 11 j
New partnership to create health innovation sandbox that will test promising new technologies and build evidence to accelerate the safe adoption of technologies, including AI, in the NHS.
- MHRA regulatory reform amendments tabled in Government’s Health Billil y a 12 j
Proposed amendments to support information sharing, regulatory reform and the future development of a medical device licensing regime.
- MHRA concludes review of Avacopan Vifor following reassessment of benefit-risk balanceil y a 12 j
Avacopan Vifor is used in the treatment of some rare autoimmune diseases affecting small blood vessels.
- Cari-Anne Quinn: Turning possibility into progress – health innovation in Walesil y a 17 j
Wales’ connected health and life sciences ecosystem creates opportunities to support innovation from development through to adoption, helping new products reach patients while supporting investment an…
- Increased risk of wear and corrosion identified with certain cobalt chrome modular neck hip replacementsil y a 18 j
While most patients implanted with these hip replacements have well-functioning hips and are unlikely to develop serious problems, a small number may develop issues.
- MHRA advises against using rectal catheters sold for personal use in infantsil y a 24 j
MHRA advises parents and carers against using rectal catheters sold for personal use (known as gas and colic relievers) in babies.
- MHRA advises against the use of rectal catheters in infantsil y a 26 j
MHRA advises parents and healthcare professionals against the use of rectal catheters (known as gas and colic relievers) in babies.
- MHRA sets out position on regulation of microbiome-based medicinal productsil y a 26 j
MHRA publishes position paper clarifying the UK licencing route for microbiome-based medicines, supporting developers to bring these innovative therapies to patients.
- Vimseltinib (romvimza) approved for use in adults to treat tenosynovial giant cell tumoursil y a 30 j
As with any medicine, the MHRA will keep the safety and effectiveness of vimseltinib (romvizma) under close review.
- You've got the grades, but don't pass on your healthil y a 31 j
Medicines and medical devices regulator issues health advice for teens off to university.
- MHRA reaffirms the safety of childhood vaccinationil y a 32 j
Vaccination is one of the most effective and safest ways to protect against many serious infectious diseases
Les plus récents communiqués de ce fil défilent en direct pour les membres PPN World.